Skip to content

Form 4 filed by ARCH Venture Fund X, L.P.

ARCH Venture Fund X, L.P. filed this Form 4 on Aspen Neuroscience, Inc. with 21 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 02:50:27 UTC.

Accession
0001193125-26-444147
Filed
2026-11-02
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Aspen Neuroscience, Inc. (CIK 2124080)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-02P bought+66,666$1566,666D
Common Stock 2026-11-02C converted+187,182253,848D
Common Stock 2026-11-02C converted+298,258552,106D
Common Stock 2026-11-02C converted+286,304838,410D
Common Stock 2026-11-02C converted+295,4901,133,900D
Common Stock 2026-11-02C converted+259,9481,393,848D
Common Stock 2026-11-02P bought+66,667$1566,667D
Common Stock 2026-11-02C converted+298,258364,925D
Common Stock 2026-11-02C converted+286,304651,229D
Common Stock 2026-11-02C converted+295,490946,719D
Common Stock 2026-11-02C converted+214,3551,161,074D
Common Stock 2026-11-02P bought+1,200,000$151,200,000I See Footnote
Series Seed Convertible Preferred Stock derivative2026-11-02C converted-187,1820D
Series A-1 Convertible Preferred Stock derivative2026-11-02C converted-298,2580D
Series A-1 Convertible Preferred Stock derivative2026-11-02C converted-298,2580D
Series A-2 Convertible Preferred Stock derivative2026-11-02C converted-286,3040D
Series A-2 Convertible Preferred Stock derivative2026-11-02C converted-286,3040D
Series B Convertible Preferred Stock derivative2026-11-02C converted-295,4900D
Series B Convertible Preferred Stock derivative2026-11-02C converted-295,4900D
Series C Convertible Preferred Stock derivative2026-11-02C converted-259,9480D
Series C Convertible Preferred Stock derivative2026-11-02C converted-214,3550D